ATE306263T1 - Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere - Google Patents

Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere

Info

Publication number
ATE306263T1
ATE306263T1 AT00916179T AT00916179T ATE306263T1 AT E306263 T1 ATE306263 T1 AT E306263T1 AT 00916179 T AT00916179 T AT 00916179T AT 00916179 T AT00916179 T AT 00916179T AT E306263 T1 ATE306263 T1 AT E306263T1
Authority
AT
Austria
Prior art keywords
cyclooxygenase
inhibitor
administration
compositions
animals
Prior art date
Application number
AT00916179T
Other languages
English (en)
Inventor
J Timothy Keane
Joseph R Schuh
Alan L Scrivner
Original Assignee
Searle Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22409943&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE306263(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Searle Llc filed Critical Searle Llc
Application granted granted Critical
Publication of ATE306263T1 publication Critical patent/ATE306263T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00916179T 1999-03-10 2000-03-09 Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere ATE306263T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12364499P 1999-03-10 1999-03-10
PCT/US2000/006097 WO2000053149A2 (en) 1999-03-10 2000-03-09 Method and composition for administering a cyclooxygenase-2 inhibitor

Publications (1)

Publication Number Publication Date
ATE306263T1 true ATE306263T1 (de) 2005-10-15

Family

ID=22409943

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00916179T ATE306263T1 (de) 1999-03-10 2000-03-09 Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere

Country Status (9)

Country Link
EP (2) EP1158977B1 (de)
JP (1) JP2002538189A (de)
AT (1) ATE306263T1 (de)
AU (1) AU778538B2 (de)
CA (1) CA2363590A1 (de)
DE (1) DE60023119T2 (de)
ES (1) ES2249253T3 (de)
NZ (1) NZ513965A (de)
WO (1) WO2000053149A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003516353A (ja) * 1999-12-08 2003-05-13 ファルマシア コーポレイション ヴァルデコキシブ組成物
ATE283048T1 (de) * 1999-12-08 2004-12-15 Pharmacia Corp Cyclooxygenase-2 hemmer enthaltende zusammensetzungen mit schnellem wirkungseintritt
SK9032002A3 (en) * 1999-12-22 2003-03-04 Pharmacia Corp Dual-release compositions of a cyclooxygenase-2 inhibitor
WO2001091856A2 (en) * 2000-06-01 2001-12-06 Pharmacia Corporation Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
IL156445A0 (en) 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
AR035533A1 (es) 2001-01-26 2004-06-02 Schering Corp Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la
MXPA04002573A (es) 2001-09-21 2004-06-18 Schering Corp Tratamiento de xantoma con derivados de azetidinona como inhibidores de la absorcion de esterol.
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
KR20050033546A (ko) 2002-04-08 2005-04-12 글락소 그룹 리미티드 (2-((2-알콕시)-페닐)-시클로펜트-1-에닐) 방향족 카르보및 헤테로시클릭산 및 유도체
AR040588A1 (es) 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
GB0225548D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds
WO2004043457A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
JP2006519869A (ja) 2003-03-07 2006-08-31 シェーリング　コーポレイション 置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
EP1601668B1 (de) 2003-03-07 2008-08-27 Schering Corporation Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
CA2517572C (en) 2003-03-07 2011-12-13 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
EP1745791B1 (de) 2003-05-07 2013-06-26 Osteologix A/S Behandlung von Knorpel/Knochen-Erkrankungen mit wasserlöslichen Strontiumsalzen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585504A (en) * 1994-09-16 1996-12-17 Merck & Co., Inc. Process of making cox-2 inhibitors having a lactone bridge
CA2223154A1 (en) * 1995-06-02 1996-12-05 G.D. Searle & Co. Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US5756529A (en) * 1995-09-29 1998-05-26 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies
DK1007067T3 (da) * 1996-10-21 2002-05-06 Eurovita As Farmaceutiske præparater indeholdende Parthenium integrifolium eller dele deraf eller en ekstrakt bestanddel deraf, anvendelsen af et sådant plantemateriale til fremstilling af ...
JP2001505564A (ja) * 1996-11-19 2001-04-24 ジー．ディー．サール アンド カンパニー 抗血管新生剤としてのシクロオキシゲナーゼ―２阻害剤の使用方法
DZ2479A1 (fr) * 1997-05-05 2003-02-01 Pfizer Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
CA2363590A1 (en) 2000-09-14
ES2249253T3 (es) 2006-04-01
AU778538B2 (en) 2004-12-09
WO2000053149A2 (en) 2000-09-14
EP1637137A3 (de) 2006-07-05
AU3732600A (en) 2000-09-28
EP1637137A2 (de) 2006-03-22
DE60023119D1 (de) 2006-02-23
EP1158977A2 (de) 2001-12-05
JP2002538189A (ja) 2002-11-12
EP1158977B1 (de) 2005-10-12
EP1158977A4 (de) 2003-09-03
NZ513965A (en) 2004-04-30
WO2000053149A3 (en) 2000-12-28
DE60023119T2 (de) 2006-07-20

Similar Documents

Publication Publication Date Title
ATE306263T1 (de) Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
EP1619960A4 (de) Futtermittelformulierung für land- und wasserbewohner
DE69909298D1 (de) Verfahren zur herstellung einer zusammensetzung zum schutz eines fleischfressenden haustieres gegen krankheiten des abnormalen kohlenhydrat-metabolismus
NZ333695A (en) Method for treating gastrointestinal damage with hyperimmunised milk and hyperimmunised egg
MY109928A (en) Fatty acid treatment
NZ519980A (en) Pet food composition for treating helicobacter species in pets
ID28060A (id) Pencegahan karang gigi dengan asam polikarboksilat
ATE323480T1 (de) Zusammensetzungen, enthaltend pinolensäure sowie deren verwendung zur gesundheitserhaltung
BR9507099A (pt) Forma de dosagem método de esterilização composição esterilizante e suplemento alimentar animal compreendendo nitrito acidificado como um agente anti-microbiano
BRPI0512926A (pt) formulação de dieta para osteoartrite canina
PL1841743T3 (pl) Amidy kwasu 3-arylo-3-hydroksy-2-aminopropionowego, amidy kwasu 3-heteroarylo-3-hydroksy-2-aminopropionowego i powiązane związki o działaniu przeciwbólowym i/lub immunostymulacyjnym
MX230817B (en) Method of increasing fat firmness and improving meat quality in animals
ATE258435T1 (de) Pinolensäure gegen diabetes
MX2007001931A (es) Aditivo alimentario.
EP1550443A4 (de) Zusammensetzung gegen stressbedingte erkrankungen
WO2008075333A3 (en) Edible compositions for preventing hair loss
PT1233678E (pt) Formulacoes zootecnicas que compreendem acidos biliares
ATE385175T1 (de) Hemmung von tyrophagus putrescentiae in tierfuttermitteln
EE200300406A (et) Meetod loomasööda lisandina kasutatava D-pantoteenhappe ja/või tema soolade saamiseks
EE200300405A (et) Meetod loomasööda lisandina kasutatava D-pantoteenhappe ja/või tema soolade saamiseks
AU6245801A (en) Food for slowing down feed intake speed in dogs
ATE355741T1 (de) Verfahren zur herstellung von nährstoffen, nährstoffe und verfahren zur abgabe von nährstoffen
MX2021015590A (es) Metodos y composiciones con beneficios renales para felinos.
JP2003246728A5 (de)
UA34330A (uk) Кормова добавка для птиці

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties